These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6163497)

  • 1. Patient-controlled dose regimen of methadone for chronic cancer pain.
    Säwe J; Hansen J; Ginman C; Hartvig P; Jakobsson PA; Nilsson MI; Rane A; Anggård E
    Br Med J (Clin Res Ed); 1981 Mar; 282(6266):771-3. PubMed ID: 6163497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-controlled analgesia with oral methadone in cancer pain: preliminary report.
    Mercadante S; Sapio M; Serretta R; Caligara M
    Ann Oncol; 1996 Aug; 7(6):613-7. PubMed ID: 8879376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C; Vara F
    J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of oral methadone in treatment of cancer pain.
    Hansen J; Ginman C; Hartvig P; Jakobsson PA; Nilsson MI; Rane A; Säwe J; Anggård E
    Acta Anaesthesiol Scand Suppl; 1982; 74():124-7. PubMed ID: 6953725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
    Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
    J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese population.
    Tse DM; Sham MM; Ng DK; Ma HM
    Palliat Med; 2003 Mar; 17(2):206-11. PubMed ID: 12701853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit.
    Mercadante S
    Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial.
    Morley JS; Bridson J; Nash TP; Miles JB; White S; Makin MK
    Palliat Med; 2003 Oct; 17(7):576-87. PubMed ID: 14594148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study.
    Fisher K; Stiles C; Hagen NA
    J Pain Symptom Manage; 2004 Dec; 28(6):619-25. PubMed ID: 15589088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful use of methadone in nociceptive cancer pain unresponsive to morphine.
    Leng G; Finnegan MJ
    Palliat Med; 1994; 8(2):153-5. PubMed ID: 7521715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid-sparing effect of diclofenac in cancer pain.
    Mercadante S; Sapio M; Caligara M; Serretta R; Dardanoni G; Barresi L
    J Pain Symptom Manage; 1997 Jul; 14(1):15-20. PubMed ID: 9223838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study.
    Rhondali W; Tremellat F; Ledoux M; Ciais JF; Bruera E; Filbet M
    J Palliat Med; 2013 Nov; 16(11):1382-7. PubMed ID: 24116946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term methadone for chronic pain: a pilot study of pharmacokinetic aspects.
    Fredheim OM; Borchgrevink PC; Klepstad P; Kaasa S; Dale O
    Eur J Pain; 2007 Aug; 11(6):599-604. PubMed ID: 17113329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study.
    Porta-Sales J; Garzón-Rodríguez C; Villavicencio-Chávez C; Llorens-Torromé S; González-Barboteo J
    Oncologist; 2016 Aug; 21(8):981-7. PubMed ID: 27306912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report.
    Salpeter SR; Buckley JS; Buckley NS; Bruera E
    J Palliat Med; 2015 Feb; 18(2):114-9. PubMed ID: 25494475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid plasma concentration during switching from morphine to methadone: preliminary data.
    Mercadante S; Bianchi M; Villari P; Ferrera P; Casuccio A; Fulfaro F; Gebbia V
    Support Care Cancer; 2003 May; 11(5):326-31. PubMed ID: 12690541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral methadone for the treatment of severe pain in hospitalized children: a report of five cases.
    Shir Y; Shenkman Z; Shavelson V; Davidson EM; Rosen G
    Clin J Pain; 1998 Dec; 14(4):350-3. PubMed ID: 9874015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A four-drug pain regimen for head and neck cancers.
    Carrol EN; Fine E; Ruff RL; Stepnick D
    Laryngoscope; 1994 Jun; 104(6 Pt 1):694-700. PubMed ID: 7515139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose ratios between high dose oral morphine or equivalents and oral methadone.
    Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
    J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.